ReadyCell at the Bio-Europe Spring 2024
ReadyCell is attending BIO-Europe Spring in Barcelona. The event is expected to bring together executives from biotech and pharma companies.
Happy International Women’s Day!
With this infographic, we proudly show the key facts we have achieved in recent times in promoting gender equality and women’s rights in the company.
Promising results for a new treatment against drug-resistant tuberculosis
The article highlights the discovery of a series of azetidine derivatives, known as BGAz compounds, that exhibit potent bactericidal activity against both drug-sensitive Mycobacterium tuberculosis and multidrug-resistant TB strains.
Get to know our talented women from Readycell
In honor of the International Day of Women and Girls in Science, we present a series of videos featuring insights from our team members that explore the diverse experiences and perspectives of the talented women at ReadyCell.
New Insights into drug formulation with ready-to-use Caco-2 cells
In a recent study published in the Future Pharmacology Journal, researchers from prestigious French companies examined the impact of four polyols on the permeability of seven active pharmaceutical ingredients (APIs).
